Yoshimoto T, Yoshimoto E, Meruelo D
Department of Pathology, New York University Medical Center, New York 10016.
J Virol. 1993 Mar;67(3):1310-4. doi: 10.1128/JVI.67.3.1310-1314.1993.
The murine cationic amino acid transporter is also the receptor for murine ecotropic leukemia retrovirus (MuLV-E). Recently, we have cloned a human gene (H13) homologous to the murine ecotropic retroviral receptor (ERR). Although the human homolog is very similar to murine ERR in sequence (87.6% amino acid identity) and structure (14 transmembrane-spanning domains), the human protein fails to function as a receptor for MuLV-E. To identify amino acid residues critical for MuLV-E infection, we took advantage of this species difference and substituted human H13 and murine ERR amino acid residues. Mouse-human chimeric receptor molecules were generated by taking advantage of using common restriction sites. These studies demonstrated that extracellular domains 3 and/or 4 contain the critical amino acid residues. Oligonucleotide-directed mutagenesis was then used to create 13 individual ERR mutants containing one or two amino acids substitutions or insertions within these two extracellular domains. Substitution of as few as one amino acid residue (Tyr) at position 235 in ERR with the corresponding H13 amino acid residue Pro abrogates the ability to function as a receptor for MuLV-E infection. Conversely, substitution of just two amino acid residues at positions 240 and 242 or 242 and 244 in H13 with the corresponding amino acid residues in ERR endows H13 with the ability to function as the receptor. This observation can be utilized to significantly improve the safety of retrovirus-mediated gene therapy in humans.
小鼠阳离子氨基酸转运体也是小鼠嗜亲性白血病逆转录病毒(MuLV-E)的受体。最近,我们克隆了一个与小鼠嗜亲性逆转录病毒受体(ERR)同源的人类基因(H13)。尽管人类同源物在序列(氨基酸同一性为87.6%)和结构(14个跨膜结构域)上与小鼠ERR非常相似,但人类蛋白不能作为MuLV-E的受体发挥作用。为了鉴定对MuLV-E感染至关重要的氨基酸残基,我们利用了这种物种差异,对人类H13和小鼠ERR的氨基酸残基进行了替换。通过利用共同的限制性酶切位点,构建了小鼠-人类嵌合受体分子。这些研究表明,细胞外结构域3和/或4包含关键的氨基酸残基。然后,使用寡核苷酸定向诱变技术在这两个细胞外结构域内创建了13个单独的ERR突变体,每个突变体包含一个或两个氨基酸替换或插入。将ERR中第235位的单个氨基酸残基(酪氨酸)替换为相应的H13氨基酸残基脯氨酸,就会消除其作为MuLV-E感染受体的功能。相反,将H13中第240和242位或242和244位的两个氨基酸残基替换为ERR中的相应氨基酸残基,可使H13具备作为受体的功能。这一发现可用于显著提高逆转录病毒介导的人类基因治疗的安全性。